Letter

Biobanking

Opt-out from biobanks better respects patients’ autonomy

BMJ 2008; 337 doi: 10.1136/bmj.a1580 (Published 10 September 2008)
Cite this as: BMJ 2008;337:a1580

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Linus Johnsson, student1,
  2. Mats G Hansson, professor1,
  3. Stefan Eriksson, senior researcher1,
  4. Gert Helgesson, senior researcher2
  1. 1Centre for Research Ethics and Bioethics, Uppsala University, Uppsala Science Park, SE-751 85 Uppsala, Sweden
  2. 2Unit for Bioethics, LIME, Karolinska Institutet, Berzelius väg 3, SE-171 77 Stockholm
  1. linus.johnsson{at}crb.uu.se

    We found that dissent to storage and use of samples by Swedish healthcare biobanks is rare and does not pose a threat to research, concluding that the results give prima facie reason to consider a move to an opt-out system.1

    Laurie presented two controversies as evidence that …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular